Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
787 | 2980 | 36.4 | 82% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
702 | 12214 | TYPE 1 DIABETES//DIABETIC KETOACIDOSIS//BARBARA DAVIS CHILDHOOD DIABET |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ISLET CELL ANTIBODIES | Author keyword | 116 | 67% | 4% | 105 |
2 | IA 2 | Author keyword | 106 | 81% | 2% | 64 |
3 | INSULIN AUTOANTIBODIES | Author keyword | 80 | 67% | 2% | 72 |
4 | LADA | Author keyword | 48 | 59% | 2% | 55 |
5 | LATENT AUTOIMMUNE DIABETES IN ADULTS | Author keyword | 48 | 73% | 1% | 37 |
6 | GADA | Author keyword | 39 | 65% | 1% | 37 |
7 | BARBARA DAVIS CHILDHOOD DIABET | Address | 35 | 19% | 5% | 160 |
8 | IA 2 ANTIBODIES | Author keyword | 33 | 83% | 1% | 19 |
9 | FOR ERGRP DIABET | Address | 24 | 56% | 1% | 29 |
10 | GAD65 | Author keyword | 21 | 31% | 2% | 58 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ISLET CELL ANTIBODIES | 116 | 67% | 4% | 105 | Search ISLET+CELL+ANTIBODIES | Search ISLET+CELL+ANTIBODIES |
2 | IA 2 | 106 | 81% | 2% | 64 | Search IA+2 | Search IA+2 |
3 | INSULIN AUTOANTIBODIES | 80 | 67% | 2% | 72 | Search INSULIN+AUTOANTIBODIES | Search INSULIN+AUTOANTIBODIES |
4 | LADA | 48 | 59% | 2% | 55 | Search LADA | Search LADA |
5 | LATENT AUTOIMMUNE DIABETES IN ADULTS | 48 | 73% | 1% | 37 | Search LATENT+AUTOIMMUNE+DIABETES+IN+ADULTS | Search LATENT+AUTOIMMUNE+DIABETES+IN+ADULTS |
6 | GADA | 39 | 65% | 1% | 37 | Search GADA | Search GADA |
7 | IA 2 ANTIBODIES | 33 | 83% | 1% | 19 | Search IA+2+ANTIBODIES | Search IA+2+ANTIBODIES |
8 | GAD65 | 21 | 31% | 2% | 58 | Search GAD65 | Search GAD65 |
9 | IA 2A | 21 | 78% | 0% | 14 | Search IA+2A | Search IA+2A |
10 | IA 2 BETA | 21 | 90% | 0% | 9 | Search IA+2+BETA | Search IA+2+BETA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ISLET CELL ANTIBODIES | 352 | 57% | 14% | 412 |
2 | INSULIN AUTOANTIBODIES | 173 | 72% | 4% | 134 |
3 | GLUTAMIC ACID DECARBOXYLASE | 154 | 21% | 22% | 668 |
4 | POSITIVE RELATIVES | 122 | 95% | 1% | 40 |
5 | ISLET CELL ANTIGEN 512 | 114 | 95% | 1% | 38 |
6 | LADA | 91 | 85% | 2% | 47 |
7 | IA 2 | 88 | 68% | 3% | 77 |
8 | IDDM | 87 | 16% | 16% | 482 |
9 | ANTIBODY POSITIVE RELATIVES | 62 | 90% | 1% | 27 |
10 | IA 2 BETA | 51 | 91% | 1% | 21 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
MECHANISMS OF DISEASE - THE PATHOGENESIS OF INSULIN-DEPENDENT DIABETES-MELLITUS | 1994 | 658 | 87 | 54% |
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies | 2011 | 226 | 430 | 22% |
The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure | 2003 | 153 | 105 | 50% |
Immune therapy in type 1 diabetes mellitus | 2013 | 16 | 71 | 82% |
Progress in immune-based therapies for type 1 diabetes | 2013 | 20 | 111 | 68% |
Clinical Applications of Diabetes Antibody Testing | 2010 | 56 | 79 | 84% |
Type 1 diabetes: new perspectives on disease pathogenesis and treatment | 2001 | 646 | 74 | 22% |
Primary and secondary prevention of Type 1 diabetes | 2013 | 19 | 38 | 63% |
Antoantigens IA-2 and GAD in type I (insulin-dependent) diabetes | 1999 | 127 | 94 | 77% |
The many faces of diabetes: a disease with increasing heterogeneity | 2014 | 25 | 97 | 31% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BARBARA DAVIS CHILDHOOD DIABET | 35 | 19% | 5.4% | 160 |
2 | FOR ERGRP DIABET | 24 | 56% | 1.0% | 29 |
3 | SKANE UNIV HOSP SUS | 16 | 54% | 0.7% | 21 |
4 | EXPT MED SECT | 13 | 37% | 0.9% | 28 |
5 | INFORMAT BIOSTAT | 10 | 38% | 0.7% | 22 |
6 | HLTH SCI BARBARA DAVIS CHILDHOOD DIABET | 9 | 83% | 0.2% | 5 |
7 | TYPE DIABET 1 | 7 | 39% | 0.5% | 14 |
8 | DEAR AVENIR | 7 | 46% | 0.4% | 11 |
9 | HLA DNA | 6 | 80% | 0.1% | 4 |
10 | ROBERT H WILLIAMS | 5 | 36% | 0.4% | 12 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000201893 | ACCELERATOR HYPOTHESIS//NUTR METAB DIS CLIN//BETA CELL AUTOIMMUNITY |
2 | 0.0000183350 | NOD MOUSE//NOD MICE//JULIA MCFARLANE DIABET |
3 | 0.0000171007 | IDDM2//INS VNTR//INSULIN GENE |
4 | 0.0000143830 | GABA SYNTHESIS//GLUTAMATE DECARBOXYLASE//GAMMA VINYL GAMMA AMINOBUTYRIC ACID |
5 | 0.0000142148 | BB RAT//GIMAP5//IMMUNOGENET INFLAMMATORY DIS |
6 | 0.0000133558 | FULMINANT TYPE 1 DIABETES//HEPATIC GLYCOGENOSIS//MAURIAC SYNDROME |
7 | 0.0000106760 | ENCEPHALOMYOCARDITIS VIRUS//EMC D//IFIH1 |
8 | 0.0000074295 | INSULIN AUTOIMMUNE SYNDROME//INSULIN ALLERGY//INSULIN ANTIBODIES |
9 | 0.0000057563 | AUTOIMMUNE THYROID DISEASE//HASHIMOTOS THYROIDITIS//AUTOIMMUNE THYROIDITIS |
10 | 0.0000047133 | GLIMEPIRIDE//JTT 608//SECONDARY FAILURE |